510(k) device
Refobacin Bone Cement R (110034355)
Biomet France · Bone Cement (LOD, Class II) · First FDA decision Apr 15, 2026, newest Apr 15, 2026Hip osteoarthritisKnee osteoarthritis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
3
Naming "Refobacin"
MAUDE reports
0
Brand "Refobacin", since 2015
PubMed studies
63
Mentioning "Refobacin"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Refobacin Bone Cement R (110034355)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Lumbar Artificial Disc Replacement (LADR)National determinationOn the books150.10Updated Nov 4, 2026
- Transcatheter Tricuspid Valve Replacement (TTVR)National analysisReview closedCAG-00467NUpdated Sep 24, 2026
- Transcatheter Aortic Valve Replacement (TAVR)National analysisReview closedCAG-00430RUpdated Sep 23, 2026
- Transcatheter Aortic Valve Replacement (TAVR)National analysisReview closedCAG-00430NUpdated Sep 23, 2026
- Lumbar Artificial Disc Replacement (LADR)National analysisReview closedCAG-00292RUpdated Sep 18, 2026
- Lumbar Artificial Disc ReplacementNational analysisReview closedCAG-00292NUpdated Sep 18, 2026
- Prothrombin Time (PT) and Partial Thromboplastin Time (PTT) tests (Removal of Unspecified Joint Replacements)Coding analysisReview closedCAG-00246NUpdated Sep 15, 2026
- Transcatheter Aortic Valve Replacement (TAVR) for Aortic Regurgitation (AR)National analysisUnder reviewCAG-00430R3Updated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Refobacin", any status and sponsor, newest update first.
Zimmer BiometPublic (ZBH)
NCT06699160 · 0 participants · Start Aug 2025 · Primary completion Dec 2030
Device: Revision arthroplasty · For: Revision Arthroplasty
Sites: Utrecht, Netherlands
University of AarhusAcademic, hospital or other
NCT00175162 · 0 participants
Device: Osteopal G vs. Refobacin-Palacos R bone cement · For: Osteoarthritis
Sites: Aarhus, Denmark
- Undisplaced Femoral Neck Fractures in the Elderly: A Trial Comparing Internal Fixation to HemiarthroplastyPivotal-lookingStatus unknown
University Hospital, AkershusAcademic, hospital or other
NCT01770769 · 220 participants · Start Feb 6, 2012 · Primary completion Feb 6, 2020
Device: Hemi - arthroplasty; internal fixation · For: Femoral Neck Fractures
Sites: Lillestrøm, Norway
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Refobacin", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LOD
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Refobacin"[tiab]. The summary above synthesizes these.
- A prospective randomized study of Refobacin Bone Cement R versus Palacos R + G.
Angelomenos V, Mohaddes M, Kärrholm J, et al. · Bone Joint J · 2024Randomized Controlled Trial, Comparative Study
- Bone cement product and failure in total knee arthroplasty.
Birkeland Ø, Espehaug B, Havelin LI, et al. · Acta Orthop · 2017Multicenter Study
- Comparison of femoral component migration between Refobacin bone cement R and Palacos R + G in cemented total hip arthroplasty: A randomised controlled roentgen stereophotogrammetric analysis and clinical study.
van der Voort P, Valstar ER, Kaptein BL, et al. · Bone Joint J · 2016Randomized Controlled Trial
- [In vitro studies on various PMMA bone cements: a first comparison of new materials for arthroplasty].
Kock HJ, Huber FX, Hillmeier J, et al. · Z Orthop Unfall · 2008Comparative Study, English Abstract
- Two-year fixation and ten-year clinical outcomes of total knee arthroplasty inserted with normal-curing bone cement and slow-curing bone cement: A randomized controlled trial in 54 patients.
Breddam Mosegaard S, Rytter S, Madsen F, et al. · Knee · 2021Randomized Controlled Trial
- The Primary Stability of a Bioabsorbable Poly-L-Lactic Acid Suture Anchor for Rotator Cuff Repair Is Not Improved with Polymethylmethacrylate or Bioabsorbable Bone Cement Augmentation.
Güleçyüz MF, Kraus-Petersen M, Schröder C, et al. · HSS J · 2018
- Antibiotic release and antibacterial efficacy in cement spacers and cement beads impregnated with different techniques: In vitro study.
Atc T, Şahin N, Çavun S, et al. · Eklem Hastalik Cerrahisi · 2018
- [27 years experiences with transtympanic aminoglycoside treatment of Menière's disease].
Lange G · Laryngorhinootologie · 1995English Abstract
- Mechanical Properties and Functional Assessment of PMMA Bone Cements Modified with Glassy Carbon.
Karpiski R, Szabelski J · J Funct Biomater · 2025
- Implant fracture of the Regenerex® modular metal tibial component: A report of three cases.
Rytter S, Madsen F, Jepsen CF, et al. · Knee · 2019Randomized Controlled Trial
- A multi-modal strategy for enhancing titanium-bone interface strength and antimicrobial properties of PMMA bone cements.
Weber S, Lewis SH, de Lucena FS, et al. · Mater Des · 2026
Other devices of this type
Also filed under product code LOD.
- Norian Srs Bone CementSynthes (Usa) · PMA 2000
- Cemex System Genta Fast Bone CementExactech, Inc. · 510(k) 2004
- SPECTRUM GV Bone CementOsteoremedies, LLC · 510(k) 2025
- PALACOS R pro, PALACOS R+G pro, PALACOS MV+G proHeraeus Medical GmbH · 510(k) 2021
- Osteopal® VHeraeus Medical GmbH · 510(k) 2024
- Bone Cement Genta, Bone Cement HV, Bone Cement LVTecres S.P.A. · 510(k) 2023
- Bone Cement-Normal ViscosityBiomecanica Industria E Comerciode Produtos Ortopedicos Ltda · 510(k) 2022
- OGM 1 Polymethylmethacrylate (PMMA) bone cementOrmed Grup Medikal Turizm Saglik Hizmetleri Sanayi VE · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.